NEW YORK, Sept. 25, 2023 -- Immunovant, Inc. , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that it will report...
Related Keywords
Chau Cheng , Nasdaq , Globenewswire Inc , Immunovant Inc , , Markets ,
comparemela.com © 2020. All Rights Reserved.